



| カタログ番号 | YP862016 |
|---|---|
| 説明 |
Bavituximab (YP862016) is a research-grade recombinant antibody targeting Phosphatidylserine. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 種反応性 | General |
| アプリケーション | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 宿主種 | Chimeric |
| クローン性 | Monoclonal |
| アイソタイプ | IgG1-kappa |
| 発現システム | Mammalian cells |
| ターゲット | Phosphatidylserine |
| エンドトキシンレベル | < 10 EU/mg |
| 純度 | >95% purity as determined by SDS-PAGE. |
| 精製 | Protein A/G purified from cell culture supernatant. |
| アクセッション番号 | 1446756-47-3 |
| RRID | Anti-Phosphatidylserine Reference Antibody (Bavituximab, RUO) (abinScience Cat# YP862016, RRID:AB_3751823) |
| 形態 | Liquid |
| 保存バッファー | 0.01M PBS pH 7.4 データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 別名 | Tarvacinch3 G4, CAS: 648904-28-3 |
| 背景 | Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a phosphatidylserine (PS)-targeting monoclonal antibody, suppresses tumor growth by targeting tumor vasculature and reactivating antitumor immunity. Bavituximab plus Paclitaxel and Carboplatin, have enhanced inhibition on non-small-cell lung cancer. • Phosphatidylserine and the human brain., PMID:25933483 • The distribution and function of phosphatidylserine in cellular membranes., PMID:20192774 • Phosphatidylserine transport in cell life and death., PMID:37413778 • Phosphatidylserine., PMID:10541030 • Phosphatidylserine: A Novel Target for Ischemic Stroke Treatment., PMID:39456225 • Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis., PMID:33539192 • Phosphatidylserine externalization as immune checkpoint in cancer., PMID:38573347 • Phosphatidylserine: A comprehensive overview of synthesis, metabolism, and nutrition., PMID:39097133 • Dynamics of phagocytosis mediated by phosphatidylserine., PMID:36281986 • Flagging fusion: Phosphatidylserine signaling in cell-cell fusion., PMID:33581114 |
| 注意事項 | For research use only. Not suitable for clinical or therapeutic use. |

SEC-HPLC detection for Research Grade Bavituximab.

SDS-PAGE for Research Grade Bavituximab




+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206

中文
English
한국어
日本語
Español
Français
Русский